UnknownPhase 2NCT00793195

Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?

Studying Short bowel syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: The Hospital for Sick Children
Principal Investigator: Paul Wales, M.D
The Hospital for Sick Children
Intervention: Intralipid 20%(drug)
Enrollment: 24 enrolled
Eligibility: All sexes
Timeline: 2009 – 2012

Study locations (5)

Alberta Children's Hospital, Calgary, Alberta, Canada
Foothills Medical Center, Calgary, Alberta, Canada
Stollery Children's Hospital, Edmonton, Alberta, Canada
Hamilton Health Sciences, Hamilton, Ontario, Canada
The Hospital for Sick Children, Toronto, Ontario, Canada

Collaborators

Fresenius Kabi

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00793195 on ClinicalTrials.gov

Other trials for Short bowel syndrome

Additional recruiting or active studies for the same condition.

See all trials for Short bowel syndrome →

← Back to all trials